The TREM2 antibody: A new player in atherosclerosis
A new study has investigated the mechanisms by which the receptor TREM2 affects atherosclerosis and a possible therapeutic approach using an agonistic TREM2 antibody.
Mar 12, 2024
0
31
A new study has investigated the mechanisms by which the receptor TREM2 affects atherosclerosis and a possible therapeutic approach using an agonistic TREM2 antibody.
Mar 12, 2024
0
31
On Jan. 31, aducanumab, a pricey drug approved for treatment of early-stage Alzheimer's disease, was withdrawn from the market. And in early March, the Food and Drug Administration delayed its decision regarding whether to ...
Mar 14, 2024
0
0
Monitoring daily activity patterns using a wrist-worn device may detect early warning signs of Alzheimer's disease, according to a recent study led by researchers at the Johns Hopkins Bloomberg School of Public Health.
Mar 11, 2024
0
0
Early stages of neurodegenerative disorders are characterized by the accumulation of proteins in discrete populations of brain cells and the degeneration of these cells. For most diseases, this selective vulnerability pattern ...
Mar 11, 2024
0
2
University of Virginia School of Medicine scientists have found important answers about strokes, heart attacks, and cardiovascular diseases by probing the biological glue our bodies create to protect us from those deadly ...
Mar 11, 2024
0
0